GI bleed nursing: assessment, interventions, and clinical management

Gastrointestinal (GI) bleeding is one of the most common emergencies nursing students encounter in med-surg, ICU, and ED rotations. Upper GI bleeding alone has an incidence of roughly 67 per 100,000 population, with in-hospital mortality around 10%. Rapid identification of the bleeding source, aggressive hemodynamic stabilization, and targeted nursing interventions determine whether a patient stabilizes or deteriorates into hemorrhagic shock. This reference covers everything nursing students need: upper versus lower GI bleed comparison, pathophysiology, clinical presentation, risk stratification scoring, priority nursing assessments and interventions, variceal management, key lab values, and NCLEX-focused review points.

Use this alongside the nursing lab values cheat sheet and the liver failure nursing reference for a complete GI emergency knowledge base.

Upper versus lower GI bleeding

The ligament of Treitz — the suspensory ligament anchoring the duodenojejunal junction — is the anatomic dividing line. Everything proximal (esophagus, stomach, duodenum) is upper GI. Everything distal (jejunum, ileum, colon, rectum) is lower GI. This distinction matters because the causes, presentation, diagnostic workup, and urgency differ substantially between the two.

A critical clinical pearl: hematochezia from an upper GI source indicates a massive, brisk bleed — blood is moving through the GI tract so fast it does not have time for enzymatic digestion. This carries a significantly higher mortality risk than the typical melena presentation.

Upper GI bleeding

Definition and anatomy

Upper GI bleeding originates proximal to the ligament of Treitz. The esophagus, stomach, and duodenum are the three primary sites. Upper GI bleeds account for roughly two-thirds of all GI hemorrhage cases and carry higher mortality than lower GI bleeds due to the larger caliber blood vessels supplying these structures.

Causes

Peptic ulcer disease (PUD) is the most common cause, responsible for approximately 40% of upper GI bleeds. The ulcer erodes into a submucosal blood vessel. Posterior duodenal ulcers are particularly dangerous because they can erode into the gastroduodenal artery, causing massive hemorrhage.

Other causes include:

• Esophageal varices — dilated submucosal veins in the esophagus caused by portal hypertension in cirrhotic patients. Variceal bleeds carry mortality rates of 15–25% per episode and are covered in detail in the liver failure nursing reference.
• Mallory-Weiss tear — a mucosal laceration at the gastroesophageal junction, classically from forceful retching or vomiting. Usually self-limiting.
• Erosive gastritis/esophagitis — mucosal inflammation from NSAIDs, alcohol, stress, or Helicobacter pylori infection.
• Dieulafoy lesion — an abnormally large submucosal artery that erodes through the mucosa without an overlying ulcer. Rare but causes massive bleeding.
• Gastric antral vascular ectasia (GAVE) — also called watermelon stomach due to its endoscopic appearance. Common in cirrhosis and autoimmune disease.
• Aortoenteric fistula — an abnormal communication between the aorta and the duodenum, most often a complication of prior aortic graft surgery. Produces catastrophic hemorrhage.
• Malignancy — gastric or esophageal cancer with tumor erosion into blood vessels.

Clinical presentation

The hallmark presentations of upper GI bleeding are:

• Hematemesis — vomiting of blood. Bright red blood indicates active, brisk bleeding. Coffee-ground emesis (dark, granular material) indicates slower bleeding where gastric acid has oxidized hemoglobin to hematin.
• Melena — black, tarry, foul-smelling stools. The dark color comes from bacterial degradation and oxidation of hemoglobin as blood passes through the GI tract. As little as 50–100 mL of blood in the upper GI tract can produce melena.
• Hematochezia — bright red blood per rectum from an upper source indicates a massive bleed (>1,000 mL) moving rapidly through the tract. This is a high-mortality presentation.

Hemodynamic changes reflect the volume of blood lost:

• <15% blood volume loss: resting tachycardia, anxiety
• ~15% blood volume loss: orthostatic hypotension (an early and important sign)
• ~40% blood volume loss: supine hypotension, altered level of consciousness, cool/clammy skin

Risk stratification

The Glasgow-Blatchford Score (GBS) is used pre-endoscopy to determine whether a patient needs urgent intervention or can be managed as an outpatient. It uses BUN, hemoglobin, systolic BP, heart rate, presence of melena, syncope, hepatic disease, and heart failure. A GBS of 0 identifies very low-risk patients who may be discharged for outpatient endoscopy.

The Rockall Score has a pre-endoscopy version (age, comorbidity, hemodynamics) and a post-endoscopy version that adds endoscopic findings. It predicts rebleeding risk and mortality.

Lower GI bleeding

Definition and causes

Lower GI bleeding originates distal to the ligament of Treitz, involving the small bowel, colon, and rectum. It accounts for roughly one-third of GI hemorrhage cases and has a lower mortality rate (<4%) compared to upper GI bleeding.

Diverticulosis is the most common cause in adults over 40. Diverticula develop at points where vasa recta penetrate the colonic wall, creating weak spots. Arterial bleeding occurs when a blood vessel within the diverticulum erodes. The bleeding is typically painless and self-limiting in 80% of cases — but the remaining 20% can bleed briskly.

Other causes include:

• Angiodysplasia (arteriovenous malformations) — abnormal, dilated blood vessels in the colonic mucosa. The most common cause of lower GI bleeding in patients over 65. Associated with aortic stenosis (Heyde syndrome) and chronic kidney disease.
• Colorectal cancer and polyps — tumor erosion into blood vessels or polyp trauma produces occult or overt bleeding.
• Inflammatory bowel disease — both Crohn’s disease and ulcerative colitis cause mucosal ulceration and bleeding. The distinction between the two conditions affects long-term management.
• Ischemic colitis — reduced blood flow to the colon (often at watershed areas like the splenic flexure) causes mucosal necrosis and bloody diarrhea with cramping abdominal pain. Common in elderly patients with atherosclerosis.
• Hemorrhoids and anal fissures — the most common cause of bright red blood on toilet paper or on the surface of stool. Usually benign, though they must be distinguished from more serious sources.
• Post-polypectomy bleeding — delayed hemorrhage 5–14 days after colonoscopic polyp removal.

Clinical presentation

The typical presentation is hematochezia — bright red or maroon blood per rectum. The color helps localize the source:

• Bright red blood suggests a distal colonic or rectal source (sigmoid, rectum)
• Maroon stools suggest a more proximal colonic or small bowel source
• Melena can occur with small bowel bleeding (proximal lower GI) if transit time is slow enough for bacterial degradation

Most lower GI bleeds (80–85%) resolve spontaneously. Patients who continue bleeding, become hemodynamically unstable, or require transfusion of more than 2 units of packed red blood cells need urgent colonoscopy or CT angiography.

Nursing assessment and monitoring

Thorough assessment is the foundation of GI bleed management. Hemodynamic status can change rapidly, and the nurse is often the first to detect early deterioration.

Vital signs and hemodynamic monitoring

• Heart rate: tachycardia is the earliest hemodynamic response to blood loss. A heart rate >100 bpm in a GI bleed patient warrants immediate investigation. Remember that beta-blockers (common in cirrhotic patients on propranolol) can mask tachycardia.
• Blood pressure: check for orthostatic hypotension — a drop of ≥20 mmHg systolic or ≥10 mmHg diastolic when moving from supine to standing. This indicates approximately 15% blood volume loss and often appears before supine BP changes. Use the vital signs reference to compare age-appropriate norms.
• Respiratory rate and SpO2: tachypnea may indicate compensatory response to decreased oxygen-carrying capacity. Monitor for aspiration risk in patients with active hematemesis.
• Temperature: fever in a GI bleed patient raises concern for sepsis from bacterial translocation through compromised gut mucosa.

Stool assessment

Document every stool for color, consistency, and estimated volume:

• Melena: black, tarry, characteristically foul-smelling — indicates upper GI or proximal lower GI source
• Hematochezia: bright red blood per rectum — indicates lower GI source (or massive upper GI bleed)
• Maroon stools: mixed bright and dark blood — suggests proximal colonic or distal small bowel source
• Occult blood: not visible — detected by guaiac or immunochemical fecal occult blood testing

Track stool frequency and volume to estimate ongoing blood loss. A sudden change from melena to hematochezia may indicate rebleeding or acceleration of hemorrhage.

Abdominal assessment

Perform a systematic abdominal assessment including:

• Inspection: distension, visible pulsations, skin changes (spider angiomata and caput medusae suggest portal hypertension and variceal bleeding risk)
• Auscultation: hyperactive bowel sounds suggest blood in the GI tract (blood acts as a cathartic). Absent bowel sounds raise concern for perforation or peritonitis.
• Palpation: tenderness, guarding, and rigidity. Rebound tenderness or a rigid abdomen suggests perforation — this is a surgical emergency. Pain with pancreatitis is also in the differential.
• Rectal exam: assess for hemorrhoids, fissures, masses, and stool color

Lab monitoring

Serial laboratory monitoring is essential. Draw labs on arrival and repeat every 4–6 hours during active bleeding. Refer to the nursing lab values cheat sheet for normal ranges.

Fluid balance and access

• Establish two large-bore peripheral IV lines (18-gauge minimum, ideally 16-gauge or larger) immediately upon arrival. Large-bore access allows rapid crystalloid and blood product infusion.
• If peripheral access is inadequate, a central venous catheter (cordis or introducer sheath) provides high-flow access.
• Maintain strict intake and output (I&O) monitoring. Include all IV fluids, blood products, and oral intake against urine output, emesis, and estimated stool blood loss.
• Insert a Foley catheter for continuous urine output monitoring. Target urine output ≥0.5 mL/kg/hr as a marker of adequate renal perfusion.

Priority nursing interventions

When a patient presents with a GI bleed, systematic prioritization prevents critical steps from being missed. Use the ADPIE nursing process to organize your approach, and communicate urgently with the healthcare team using SBAR.

Airway and aspiration prevention

Patients with active hematemesis face significant aspiration risk. Position the head of bed at 30–45 degrees to reduce aspiration risk. If the patient has altered mental status or cannot protect their airway, notify the provider immediately — endotracheal intubation may be necessary before endoscopy. Avoid non-invasive positive pressure ventilation (NIPPV) in actively vomiting patients because it increases aspiration risk.

Circulatory support and fluid resuscitation

• Start crystalloid infusion (normal saline or lactated Ringer’s) immediately through both large-bore IVs.
• Packed red blood cell (PRBC) transfusion: initiate when hemoglobin drops below 7 g/dL in hemodynamically stable patients. Use a threshold of 8 g/dL in patients with active cardiovascular disease (history of MI, heart failure, or acute coronary syndrome).
• Massive transfusion protocol (MTP): activate when the patient has lost or is projected to lose more than one blood volume (approximately 70 mL/kg). MTP delivers PRBCs, fresh frozen plasma, and platelets in a balanced ratio (typically 1:1:1).
• Monitor for transfusion reactions: fever, chills, urticaria, hypotension, dyspnea. Stop the transfusion immediately if a reaction occurs.

NPO and endoscopy preparation

• Place the patient NPO (nothing by mouth) to prepare for endoscopy.
• EGD (esophagogastroduodenoscopy) is the primary diagnostic and therapeutic tool for upper GI bleeds. Timing: within 24 hours for most patients, within 12 hours for high-risk presentations (hemodynamic instability, bloody NG aspirate, high Glasgow-Blatchford Score).
• Colonoscopy is the primary tool for lower GI bleeds after bowel preparation.
• A prokinetic agent (erythromycin IV) may be administered 30–90 minutes before EGD to accelerate gastric emptying and improve endoscopic visualization.

Medication management

Understand the rationale for each medication class in GI bleed management. Refer to the drug classifications reference for broader pharmacology context.

• Proton pump inhibitors (PPIs): IV pantoprazole is the standard. An 80 mg bolus followed by 8 mg/hour continuous infusion stabilizes clots by maintaining gastric pH above 6. This is first-line for all suspected upper GI bleeds.
• Octreotide (somatostatin analog): reduces splanchnic blood flow and portal pressure. First-line pharmacotherapy for suspected variceal bleeding. Typical dose: 50 mcg IV bolus followed by 50 mcg/hour infusion for 3–5 days.
• Antibiotic prophylaxis: IV ceftriaxone 1 g daily for cirrhotic patients with GI bleeding. Cirrhosis impairs gut barrier function, and GI bleeding increases bacterial translocation risk, which leads to sepsis.
• Anticoagulant reversal agents: for patients on warfarin with INR >2 — four-factor prothrombin complex concentrate (PCC) provides rapid reversal. For heparin — protamine sulfate. For direct oral anticoagulants (DOACs) — idarucizumab reverses dabigatran; andexanet alfa reverses factor Xa inhibitors (rivaroxaban, apixaban).
• Vasopressin: used in refractory variceal bleeding to constrict splanchnic vessels. Always co-administer nitroglycerin to prevent coronary vasoconstriction and cardiac ischemia.

Patient education

• Avoid NSAIDs (ibuprofen, naproxen, aspirin) — these inhibit prostaglandin synthesis, reducing the protective mucosal barrier and promoting ulcer formation.
• Limit alcohol intake — alcohol is a direct irritant to gastric mucosa and worsens portal hypertension in cirrhotic patients.
• Complete H. pylori eradication therapy if testing is positive — triple therapy (PPI + clarithromycin + amoxicillin) for 14 days reduces recurrent ulcer hemorrhage.
• Recognize and report warning signs: black tarry stools, vomiting blood, dizziness on standing, rapid heartbeat, weakness.
• Take prescribed PPIs as directed for ulcer prophylaxis.

Escalation triggers

Use SBAR communication and escalate immediately when:

• Heart rate >120 bpm or rising trend despite fluid resuscitation
• Systolic BP <90 mmHg or not responding to crystalloid boluses
• Urine output <0.5 mL/kg/hr for 2 consecutive hours
• Ongoing hematemesis or increasing hematochezia
• Altered level of consciousness — confusion, agitation, or decreasing Glasgow Coma Scale score
• Lactate >4 mmol/L or rising serial lactate despite intervention
• Hemoglobin drop >2 g/dL between serial draws (4–6 hours apart)

Variceal bleeding: special considerations

Variceal hemorrhage deserves separate attention because the pathophysiology, management priorities, and mortality risk differ from nonvariceal GI bleeding. Esophageal varices develop when portal hypertension (most commonly from cirrhosis) forces blood through collateral venous pathways. The submucosal veins of the esophagus dilate under this pressure. When varices rupture, the hemorrhage is typically massive and carries 15–25% mortality per episode. See the liver failure reference for the underlying pathophysiology of portal hypertension and cirrhosis.

Pharmacologic management

• Octreotide is first-line — reduces portal pressure by inhibiting vasodilatory hormone release from the splanchnic circulation. Start immediately upon suspicion of variceal bleeding, before endoscopic confirmation.
• Antibiotics (ceftriaxone 1 g IV daily) are mandatory, not optional. GI bleeding in cirrhosis dramatically increases bacterial translocation and infection rates.
• Vasopressin with nitroglycerin is a second-line alternative if octreotide is unavailable.

Endoscopic intervention

Endoscopic variceal ligation (EVL/banding) is the gold standard for acute variceal hemorrhage. Rubber bands are placed around varices to induce necrosis and hemostasis. Sclerotherapy (injection of a sclerosant into the varix) is an alternative when banding is not technically feasible.

Balloon tamponade

The Sengstaken-Blakemore tube (or Minnesota tube variant) is a last-resort bridge therapy when bleeding is uncontrolled and endoscopy cannot be performed or has failed. The tube has a gastric balloon and an esophageal balloon that compress the varices mechanically.

Critical nursing considerations for balloon tamponade:

• The patient must be intubated before insertion to protect the airway.
• The gastric balloon is inflated first, then the esophageal balloon if bleeding continues.
• Maximum esophageal inflation time is typically 24 hours — prolonged inflation causes esophageal necrosis and perforation.
• Keep scissors at the bedside at all times to cut the tube and release the balloons immediately if the tube migrates and obstructs the airway.
• This is temporary — definitive treatment (endoscopy or TIPS) must follow.

TIPS procedure

Transjugular intrahepatic portosystemic shunt (TIPS) creates a channel between the hepatic vein and portal vein, decompressing portal pressure. TIPS is indicated for variceal bleeding refractory to endoscopic and pharmacologic therapy. Post-TIPS nursing priorities include monitoring for hepatic encephalopathy (the shunt diverts portal blood past the liver, reducing ammonia clearance) and assessing the shunt with Doppler ultrasound.

Secondary prophylaxis

After a variceal bleed episode, nonselective beta-blockers (propranolol or nadolol) reduce portal pressure and decrease the risk of rebleeding. These are combined with repeat endoscopic variceal ligation sessions until varices are obliterated. Administer lactulose as prescribed to prevent hepatic encephalopathy — the combination of GI blood (a protein load) and impaired hepatic clearance puts cirrhotic patients at high risk for encephalopathy after a variceal bleed.

NCLEX review: 10 high-yield points

1. BUN:Cr ratio >20:1 suggests an upper GI source. The digested blood protein is absorbed in the small bowel, raising BUN disproportionately to creatinine.

2. Melena = digested blood = upper GI (or proximal lower GI with slow transit). The black, tarry appearance comes from bacterial degradation and oxidation of hemoglobin over several hours of intestinal transit.

3. Hematochezia from an upper GI source = massive bleed with high mortality. Blood is moving so rapidly through the tract that it has no time for digestion. This patient needs immediate aggressive resuscitation.

4. First priority = IV access and fluid resuscitation, not endoscopy. NCLEX prioritizes stabilization (ABCs and circulation) before diagnostic procedures. Establish two large-bore IVs and start crystalloid before anything else.

5. Octreotide is the first-line drug for variceal bleeds. It reduces portal pressure by inhibiting splanchnic vasodilation. Beta-blockers (propranolol) are for secondary prophylaxis after the acute episode resolves.

6. Orthostatic hypotension is an early hemorrhage sign. A drop of ≥20 mmHg systolic on standing indicates approximately 15% blood volume loss. This change may appear before any drop in supine blood pressure — assess orthostatics on every GI bleed patient who can safely stand.

7. Coffee-ground emesis = slow, partially digested blood. Gastric acid converts hemoglobin to hematin, producing the characteristic dark, granular appearance. This indicates the bleed has been ongoing but is not currently brisk.

8. NPO before endoscopy — always verify when the patient last ate. Endoscopy with a full stomach increases aspiration risk substantially. Check NPO status and document last oral intake.

9. Reversal agents are time-critical for anticoagulated patients. Warfarin: prothrombin complex concentrate (PCC). Heparin: protamine sulfate. Dabigatran: idarucizumab. Factor Xa inhibitors: andexanet alfa. Know which reversal agent matches which anticoagulant.

10. Monitor stool color changes as a bleeding indicator. A shift from melena to formed brown stools suggests the bleed is resolving. A shift from melena to hematochezia suggests the bleed is accelerating. Maroon-colored stools fall between upper and lower GI characteristics on the spectrum.

Related nursing references

• Nursing lab values cheat sheet — normal ranges and clinical significance for all labs discussed in this article
• Liver failure nursing reference — portal hypertension, varices, Child-Pugh scoring, hepatic encephalopathy
• Sepsis nursing reference — sepsis from bacterial translocation in GI bleeding
• AKI nursing reference — hypovolemic AKI from hemorrhage, BUN and creatinine monitoring
• CKD/ESRD nursing reference — chronic kidney disease and GI bleeding risk in dialysis patients
• Pancreatitis nursing reference — differential diagnosis for abdominal pain presentations
• Electrolyte imbalances reference — electrolyte disturbances from massive fluid resuscitation and transfusion
• ABG interpretation — metabolic acidosis from hemorrhagic shock and lactic acid accumulation
• Drug classifications nursing reference — PPI, octreotide, and anticoagulant reversal agent pharmacology
• SBAR communication — structured escalation when a GI bleed patient deteriorates
• Head-to-toe assessment — systematic physical assessment framework
• Vital signs by age — age-appropriate vital sign ranges for hemorrhage assessment